Cannabis

Supply gluts, collapsing wholesale prices and Canadian regulations put an incoming 360,000 kgs of outdoor weed at risk of going unsold

Running online Oct. 23-25, the event features key industry voices and explains the cannabis career paths of today

A recent questionnaire highlights how a taxed system with strictly commercial access leaves patients treating themselves outside official channels

Many of the firm's well-known faces took lumps in the weed sector, mistakes they say set them up for success in psychedelics

The Serious Hope Society is asking Ottawa for an exemption from federal cannabis law. Its landlord and city staff might shutter it before one can be granted

Following the OCS's release of its first-quarter report this week, attorney Trina Fraser questions the ongoing lack of transparency

Figures from 2019 vary significantly with previous news reports, which could land Health Canada in hot water if it can't explain why

Retailers pay $36K a year for a business licence, but the city's explanation for the high costs and where that money goes isn't clear

Chipping away at a backlog of applications creates challenges for operators hoping to expand

Current legal markets have been captured by corporations and fail to address the racist war on drugs, the International Drug Policy Consortium warns

To improve safety and access, officials should heed calls to authorize pharmacies, legitimize compassion clubs and support harm-reduction groups

The called-for changes could give a huge boost to local producers, if the Oct. 24 snap election doesn't backfire

Sales in the country's largest province have skyrocketed 47% since May

A detailed look at non-prescription cannabidiol in 9 countries reveals a regulatory hodgepodge outpaced by a wild west market

Without meaningful opening of the economy, the company projects further flat to modest revenue growth

As part of its legislated review of the Cannabis Act, the country should account for the impacts of enforcement on racialized communities

National Cannabis Policy Summit talks unequal enforcement, equity and how prohibition harms the entire country

The once-promising producer previewed impairment charges of $1.8B, termination of UFC deal, while appointing Miguel Martin head boss

While the MORE Act would end America's racist war on weed, it likely won't pass Congress until after November's election, expert says

Cannabis lawyer Harrison Jordan has 10 recommendations to make the act 'really kick ass from a good public policy perspective'

Canada's zany limits on weed drinks are continuing to confuse consumers and make Seth Rogen less rich

Regulated market should include, not set police on, the unregulated market, advocates say

Quebec and Manitoba initially banned cultivating cannabis at home. Meet the Canadians taking their provinces to court to change that

Tetra Bio-Pharma's results relate to other findings that high doses of CBD can cause toxicity in the liver when ingested

Its Simply Bare brand has been a hit with consumers, but can the firm translate quality product into profit? Yes, say analysts

Grass is back on the menu for most of the country's college competitors

As she advances her own career, the chemist-turned-regulatory pro takes the Canadian cannabis industry with her

The company reported a related $12.6M impairment charge in its Q3 2020 earnings

Tyler Robson explains how beverage sales are ramping up in Canada and how new emulsion tech gives his company an edge in terms of user experience

News of Vancouver's love-to-hate pub chain ditching its Hobo brandname spurned speculation the new title could be too cuddly for Canadian regs

Data suggest gummies are primed to increase sales share and there's opportunity for new brands to enter the space

'They should be ashamed of themselves,' says NORML Canada executive director

Company says the new product line is targeted at 'frequent' consumers

The white-walled, wood-accented weed retail chain has opened another location in Vancouver

Activist Neil Magnuson operates outside the regulated market to offer low-barrier weed as an alternative to dangerous street drugs

Vermont cannabis lawyer Timothy Fair calls FDA's two-year delay on CBD regulations 'beyond absurd'

Facing Covid complications, leaders of the promising sector will communicate ways to be creative today and capitalize tomorrow

Stock in dominant operator of Florida's medical market hit a record high this week

Outdoor-focused cultivator remains confident despite reporting cash position of only $14 million

The company has cut back on operating expenses in an effort to weather the current economic storm